Who owns the FELIBUMIN trademark?

The FELIBUMIN trademark is owned by Genecell Biotech Inc..

What class is the FELIBUMIN trademark registered in?

The FELIBUMIN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for FELIBUMIN?

The USPTO serial number for FELIBUMIN is 97063406.

What is the registration number for FELIBUMIN?

FELIBUMIN is registered under USPTO registration number 7051945.

Sealvo

Home Search: FELIBUMINFELIBUMIN #97063406

Back

Updated Oct 15, 2026·39 searches this week

View on USPTO TSDR Find similar marks

FEL

USPTO Trademark Record

REGISTERED

FELIBUMIN

SN 97063406·Reg 7051945·Filed Oct 07, 2021

Owner Genecell Biotech Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

FELIBUMIN (Serial No. 97063406), Registration No. 7051945, is a registered US trademark filed on Oct 07, 2021 by Genecell Biotech Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: May 16, 2029

Mark Intelligence

FELIBUMIN (Reg. #7051945) is a registered US trademark that has been protecting its owner, Genecell Biotech Inc., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 07, 2021

SERIAL

97063406

REG#

7051945

REGISTERED

May 16, 2023

Filing Information

StatusREGISTERED

Filing DateOct 07, 2021

Serial Number97063406

Registration No.7051945

Registration DateMay 16, 2023

Status DateMay 16, 2023

Published for OppositionFeb 28, 2023

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

19 events

REGISTERED-PRINCIPAL REGISTER

May 16, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 16, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 28, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 28, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 08, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 20, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 20, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 20, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 20, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Jan 19, 2023

ASSIGNED TO LIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Nov 18, 2022

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 17, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Nov 17, 2022

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

SUSPENSION LETTER WRITTEN

Jul 13, 2022

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Jul 13, 2022

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jul 13, 2022

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

ASSIGNED TO EXAMINER

Jul 12, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 01, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 11, 2021

NEW APPLICATION ENTERED

Other Marks by Genecell Biotech Inc.

Additional USPTO filings from the same owner.

CAN

CANIBUMIN

97063416

Genecell Biotech Inc.

REGISTERED

Other Marks by Jong Park

Additional USPTO filings handled by the same attorney of record.

SIT

SIT SELF-INSIGHT THERAPY

79433311

REGISTERED

LEA

LEAD VAULT

79432627

REGISTERED

MUI

MUILLI

88204358

REGISTERED

FVR

FVRTS

99219145

REGISTERED

FELIBUMIN

Run a conflict check

Other Marks by Genecell Biotech Inc.

Other Marks by Jong Park

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company